3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
46
Precursor Cell Lymphoblastic Leukemia-Lymphoma
32
Myelodysplastic Syndromes
25
Multiple Myeloma
20
Recurrence
19
Lymphoma, Non-Hodgkin
16
Lymphoma
15
Leukemia, Lymphocytic, Chronic, B-Cell
14
Lymphoma, B-Cell
13
Hematologic Neoplasms
12
Ovarian Neoplasms
10
Melanoma
10
Leukemia
10
Myeloproliferative Disorders
9
Burkitt Lymphoma
9
Lymphoma, Large B-Cell, Diffuse
8
Hodgkin Disease
8
Pancreatic Neoplasms
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia, Biphenotypic, Acute
7
Triple Negative Breast Neoplasms
6
Stomach Neoplasms
6
Osteosarcoma
6
Neuroblastoma
6
Neoplasms
6
Leukemia, Myelomonocytic, Juvenile
6
Leukemia, Myelomonocytic, Chronic
6
Breast Neoplasms
6
Neoplasm Metastasis
5
Lymphoma, Mantle-Cell
5
Interventions
pembrolizumab
14
Specimen Handling
11
Cisplatin
11
Radiotherapy
7
Magnetic Resonance Spectroscopy
7
Human Papillomavirus DNA Tests
7
Brachytherapy
7
Bevacizumab
7
Colposcopy
6
atezolizumab
5
Platinum
5
Paclitaxel
5
Nivolumab
5
Gemcitabine
5
Carboplatin
5
Blood Specimen Collection
5
Restraint, Physical
4
Radiation
4
Fulvestrant
4
Biopsy
4
lenvatinib
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Drug Therapy
3
1,2-diaminocyclohexaneplatinum II citrate
3
zimberelimab
2
tisotumab vedotin
2
spartalizumab
2
palbociclib
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
fludarabine
×
90 days
×
Clear all
No trials found.